Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Followed by dull ache in armpits and intermittent pain in hands and feet (most severe in left, injection-side hand) that still persists at time of reporting 2 months after injection.; Followed by dull ache in armpits and intermittent pain in hands and feet (most severe in left, injection-side hand) that still persists at time of reporting 2 months after injection.; Followed by dull ache in armpits and intermittent pain in hands and feet (most severe in left, injection-side hand) that still persists at time of reporting 2 months after injection.; Severe swelling/pain in both axillary lymph nodes starting a few days after 3rd (booster) injection; Severe swelling/pain in both axillary lymph nodes starting a few days after 3rd (booster) injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Dec2021 11:30 (Lot number: FL3197) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: other medical history No. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8731, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 16Apr2021, when the patient was 42 years old, for Covid-19 Immunization, reaction(s): "Covid test result=Positive", "Covid test result=Positive"; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8733, Location of injection: Left Arm , Vaccine Administration Time: 01:00 PM), administration date: 28Mar2021, when the patient was 42 years old, for Covid-19 Immunization, reaction(s): "Covid test result=Positive", "Covid test result=Positive". The following information was reported: PAIN IN EXTREMITY (non-serious), AXILLARY PAIN (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 23Dec2021, outcome "not recovered" and all described as "Followed by dull ache in armpits and intermittent pain in hands and feet (most severe in left, injection-side hand) that still persists at time of reporting 2 months after injection."; LYMPHADENOPATHY (non-serious), AXILLARY PAIN (non-serious) all with onset 23Dec2021, outcome "not recovered" and all described as "Severe swelling/pain in both axillary lymph nodes starting a few days after 3rd (booster) injection". The events "followed by dull ache in armpits and intermittent pain in hands and feet (most severe in left, injection-side hand) that still persists at time of reporting 2 months after injection.", "followed by dull ache in armpits and intermittent pain in hands and feet (most severe in left, injection-side hand) that still persists at time of reporting 2 months after injection.", "followed by dull ache in armpits and intermittent pain in hands and feet (most severe in left, injection-side hand) that still persists at time of reporting 2 months after injection.", "severe swelling/pain in both axillary lymph nodes starting a few days after 3rd (booster) injection" and "severe swelling/pain in both axillary lymph nodes starting a few days after 3rd (booster) injection" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity, axillary pain, pain in extremity, lymphadenopathy, axillary pain.  Follow-up (23Feb2022): Follow-up attempts are completed. No further information is expected.